Abstract:Objective To analyze the effects of different N stages,surgical treatment,lymph node dissection and combined chemoradiotherapy on the prognosis of intrahepatic cholangiocarcinoma (ICC).Methods The clinical data and follow-up results of 4 555 ICCs in the SEER database were retrospectively analyzed.Including 3 710 patients with N0 phase and 845 patients with N1,all patients included complete TNM staging information,survival time and survival status information,surgical related information and radiotherapy and chemotherapy treatment information.The survival curve was described by Kaplan-Meier method.The survival of 120 months was described.The hypothesis test was performed by Log-rank test.The overall prognosis of patients with different Nstage ICCs was observed.Different surgical methods,lymph nodes were removed,and postoperatively.The effect of chemoradiotherapy on the prognosis of patients with different N-stage ICC.Measurement data with skewed distribution were expressed as medians,and count data were expressed as percentages.Results The median survival time of N1 patients was 12 months while 15 months in N0 patients.In N0 patients,the median survival time was 8 months of no operation performed patients,26 months of local tumor destruction patients,and 45-59 months of surgical treatment performed patients.In N1 patients,the survival time was 9 months,26 months and 14-22 months of no operation performed,local tumor destruction and surgical treatment performed patients,respectively.In the N0 stage,the median survival time was 37 months for lymph node dissection not performed patients,and the median survival time for lymph node dissection patients was 46-55 months.In N1 patients,the median survival time was 26 months and 18-20 months for without or with lymph node dissection patients.In the N0 stage,the median survival time was 41-42 months for without chemo-or radio-therapy,and it was 43-46 months for with chemo-or radio-therapy patients.In the N1 stage,the median survival time 10-17 months and 23 months for without or with chemo-or radio-therapy patients.Conclusions The prognosis of patients with N1 in ICC is significantly worse than that in patients with N0.Surgery is an effective method for the treatment of ICC.At the same time,routine lymphadenectomy should be recommended.Patients with N1 are recommended for radiotherapy and chemotherapy.

Evaluation of the 8th Edition American Joint Commission on Cancer (AJCC) Staging System for Patients with Intrahepatic Cholangiocarcinoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis

Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis

Evaluation of Clinical Staging of the American Joint Committee on Cancer (eighth Edition) for Prostate Cancer.

Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.

Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates

Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma

Comparative Effectiveness of the Revised American Joint Committee on Cancer Staging System

Proposal Of The Optimal Numbers Of Examined And Positive Lymph Nodes To The 8th Edition Of American Joint Committee On Cancer (Ajcc) Staging For 758 Patients With Distal Cholangiocarcinoma

Evaluation of the Eighth Edition of the American Joint Committee on Cancer TNM Staging System for Gastric Cancer: an Analysis of 7371 Patients in the SEER Database

Staging, Prognostic Factors and Adjuvant Therapy of Intrahepatic Cholangiocarcinoma after Curative Resection

Application of the Eighth Edition of the American Joint Committee on Cancer Staging for Pancreatic Adenocarcinoma.

Interpretation of the TNM Classification for Intrahepatic Cholangiocarcinoma in the American Joint Committee on Cancer Cancer Staging Manual (8th Edition)

A Population‐Level Validation of the New 9th Edition of the American Joint Commission on Cancer Staging System for Anal Squamous Cell Carcinoma

Performance of the 7 th and 8 th Editions of the American Joint Committee on Cancer Staging System in Patients with Intraductal Papillary Mucinous Neoplasm-Associated PDAC : A Multi-institutional Analysis

The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication

Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision

Development and Validation of a Prognostic Score for Intrahepatic Cholangiocarcinoma

Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.

Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study

Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8 edition of the TNM staging system for esophageal cancer?

Surgical treatment and prognosis analysis of intrahepatic cholangiocarcinoma with different lymph node metastasis status